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Abstract
Background: Flexible endoscopes undergo repeated rounds of patient-use and reprocessing. Some
evidence indicates that there is an accumulation or build-up of organic material that occurs over time in
endoscope channels. This "buildup biofilm" (BBF) develops as a result of cyclical exposure to wet and dry
phases during usage and reprocessing. This study investigated whether the BBF matrix represents a greater
challenge to disinfectant efficacy and microbial eradication than traditional biofilm (TBF), which forms
when a surface is constantly bathed in fluid.
Methods: Using the MBEC (Minimum Biofilm Eradication Concentration) system, a unique modelling
approach was developed to evaluate microbial survival in BBF formed by repetitive cycles of drying,
disinfectant exposure and re-exposure to the test organism. This model mimics the cumulative effect of
the reprocessing protocol on flexible endoscopes. Glutaraldehyde (GLUT) and accelerated hydrogen
peroxide (AHP) were evaluated to assess the killing of microbes in TBF and BBF.
Results: The data showed that the combination of an organic matrix and aldehyde disinfection quickly
produced a protective BBF that facilitated high levels of organism survival. In cross-linked BBF formed
under high nutrient conditions the maximum colony forming units (CFU) reached ~6 Log10 CFU/peg.
However, if an oxidizing agent was used for disinfection and if organic levels were kept low, organism
survival did not occur. A key finding was that once established, the microbial load of BBF formed by GLUT
exposure had a faster rate of accumulation than in TBF. The rate of biofilm survival post high-level
disinfection (HLD) determined by the maximum Log10CFU/initial Log10CFU for E. faecalis and P. aeruginosa
in BBF was 10 and 8.6 respectively; significantly different compared to a survival rate in TBF of ~2 for each
organism. Data from indirect outgrowth testing demonstrated for the first time that there is organism
survival in the matrix. Both TBF and BBF had surviving organisms when GLUT was used. For AHP survival
was seen less frequently in BBF than in TBF.
Conclusion:  This BBF model demonstrated for the first time that survival of a wide range of
microorganisms does occur in BBF, with significantly more rapid outgrowth compared to TBF. This is most
pronounced when GLUT is used compared to AHP. The data supports the need for meticulous cleaning
of reprocessed endoscopes since the presence of organic material and microorganisms prevents effective
disinfection when GLUT and AHP are used. However, cross-linking agents like GLUT are not as effective
when there is BBF. The data from the MBEC model of BBF suggest that for flexible endoscopes that are
repeatedly used and reprocessed, the assurance of effective high-level disinfection may decrease if BBF
develops within the channels.
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Background
Flexible endoscopes are widely and increasingly used for
diagnostic and therapeutic procedures, e.g. colonoscopy is
the gold standard for colon cancer screening. However,
these reusable medical devices pose a unique challenge to
infection control. They are complex in design with multi-
ple long, narrow, cross-connected lumens. Due to the
material composition, the majority of flexible endoscopes
cannot be steam sterilized. Contact with mucosal surfaces
in the body necessitates a minimum of HLD. Flexible
endoscopes are repeatedly reprocessed up to a thousand
times per year. Reprocessing involves cleaning (generally
with an enzymatic detergent), HLD (most often with a liq-
uid chemical disinfectant), rinsing, drying and storage.
Spach et al. [1] described nosocomial transmission of
microorganisms by endoscopes as a result of scope con-
tamination from the patient and/or the inanimate envi-
ronment (e.g. irrigating solutions, automated endoscope
reprocessing devices). If organisms from these sources sur-
vive the reprocessing steps they could then lead to subse-
quent patient infection. Survival of the reprocessing stage
may result if the HLD concentration is inadequate (e.g.
dilution of HLD), if cleaning is inadequate or if the scope
is contaminated post-processing. Although the reported
incidence of infection transmission is very low, this has
been attributed in part to unreported or unrecognized (i.e.
infection occurs but the link with a recent endoscopic pro-
cedure is not recognized because the physician dealing
with the infection is not the physician who performed the
endoscopy) transmission. It is expected that strict adher-
ence to recommended reprocessing protocols will effec-
tively eliminate all bioburden from the endoscope (i.e.
microbes and organic matter from patient secretions).
Most reports of infection transmission have been associ-
ated with breeches in the reprocessing protocol but as
noted by Vickery et al. [2] "These studies suggest that
human error is a major issue, but we and others have
found > 2% bacterial contamination rate of patient-ready
endoscopes despite good adherence to infection control
guidelines." Nelson indicated that in reprocessed flexible
endoscopes, residual organic matter and biofilm is likely
a result of "multiple cleaning and disinfection cycles over
the life of the instrument [3]." Furthermore, there is evi-
dence of microbial survival in patient-used scopes [4,5]
including: Mycobacterium tuberculosis survival of multiple
patient-use/reprocessing cycles for 17 days; [6]Hepatitis C
virus (HCV) infection of three successive patients within a
few days in spite of reprocessing; [7] and Pseudomonas
contaminated scopes and infection of 100 out of 410
patients, attributable to a scope design flaw [8,9]. Biofilm
formation in flexible endoscopes has also been shown by
SEM or suggested by various researchers, [3,2,10,11] with
implications in facilitating infection transmission [11,12].
Despite these findings there are no prospective published
reports in the medical literature directly linking an endo-
scope, cleaned in accordance with current reprocessing
standards and guidelines and not defective in design, to
transmission of an infectious agent (biofilm associated or
not) from one patient to another patient or from the envi-
ronment to the patient.
Traditional biofilm (TBF) forms on a surface continually
bathed in fluid and exposed to microorganisms (e.g. ind-
welling lines (catheter, IV) and medical implants). Devel-
opment of traditional biofilm in endoscopes is thought to
be associated with residual moisture in remaining chan-
nels [11,2] that likely originated from water sources, e.g.
in AERs and moisture in channels involving such organ-
isms as Mycobacterium spp, Legionella spp, and Pseudomonas
aeruginosa. However, as reviewed by Pajkos et al. [11] the
gradual build up of material over repeated use in reproc-
essed flexible endoscopes forms by a very different kinetic
background. The initial stages of formation (surface con-
ditioning from patient secretions, microbial attachment,
growth and colonization) are similar to TBF. However
medical devices such as gastrointestinal (GI) endoscopes
are used repeatedly in a day, with cyclic exposure to high
levels of microbes due to contact with the mucosal surface
of the gut. In addition, each use-reprocessing cycle
involves scope exposure to hydrated phases (post patient,
cleaning, and disinfection) as well as a dry phase (during
storage). Repeated use over time can facilitate a buildup
biofilm formation (BBF) consisting of layers of dried
organic material with embedded microorganisms. Pajkos
et al. [11] reported that new endoscopes do not have soil
or biofilm in their channels but that 12 or 13 endoscopes
from 13 different hospitals did have accumulations
detected by SEM. These SEM observations support the
need to model the buildup over repeated use as it does
appear that patient-used endoscopes have accumulations
over time. We hypothesize that the resultant buildup bio-
film (BBF) would have a unique composition, microbial
proliferation, biofilm formation and survival characteris-
tics compared to TBF.
Little is known regarding the progressive buildup of resid-
ual patient material and organisms within the channels of
flexible endoscopes that are repeated reprocessed
throughout the life of the device. To accurately study
microbial survival within BBF and potential microbial
transmission, a novel model of BBF was developed that
replicates the reprocessing cycles and closely reflects the
type of buildup biofilm that develops in medical devices
that are reprocessed repeatedly. The BBF model was com-
pared to TBF using the MBEC peg model [13,14] in the
presence of high or low levels of organic material. The effi-
cacy of microbial killing for two commonly used high-
level disinfectants (glutaraldehyde, a cross-linking agent,BMC Infectious Diseases 2009, 9:56 http://www.biomedcentral.com/1471-2334/9/56
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and accelerated hydrogen peroxide, an oxidizing agent)
was compared in these BBF and TBF models.
Methods
Microorganisms and culture
Test organisms in this research project were a representa-
tive range of microorganisms that could be associated
with contamination of complex medical devices and/or
healthcare environments and included: Pseudomonas aeru-
ginosa ATCC15442, Enterococcus faecalis ATCC 29212, and
Candida albicans ATCC 14053. Bacterial organisms were
passaged on tryptic soy agar (TSA) (Oxoid, Toronto, Can-
ada) medium at 35°C aerobically for 24 to 48 hours. Fun-
gal organisms were sub-cultured on TSA supplemented
with 5% whole sheep blood (BA) (Oxoid, Toronto, Can-
ada) and incubated at 30°C aerobically for 72 hours.
Stock cultures were maintained in skim milk at -70°C. All
bacterial cultures were subcultured three times before
experimentation.
Test Disinfectants
Glutaraldehyde (Metricide™, Sybron Canada, Oakville,
Canada) at a stock concentration of 2.6% (w/v) was tested
for HLD as per APIC's currently accepted practice of 20
minutes exposure at room temperature [15,12]. The APIC
recommendation for HLD using Glutaraldehyde differs
from the manufacturer's recommended exposure time of
45 minutes at 25°C and is based on the expectation that
the flexible endoscopes have been adequately cleaned
prior to HLD. Accelerated hydrogen peroxide (PerCept,
Virox, Mississauga, Canada) was evaluated at a 7% v/v for
HLD concentration and tested as per manufacturer's rec-
ommendations (i.e. 20 minutes exposure at room temper-
ature). Any dilution of disinfectants was done using sterile
tap water, prepared immediately before each test and was
not reused.
Test soil
To provide an organic challenge that mimicked medical
device exposure in the body, an artificial test soil (ATS)
was used in all biofilm studies. ATS is composed of pro-
tein, carbohydrate, endotoxin and hemoglobin at worst-
case levels as detected in patient-used flexible endoscopes
[16,17]. The test soil without organic content was sterile
tap water (sTAP). To represent the endoscope reprocessing
conditions, an enzymatic detergent (Pentazyme (Case
Medical Inc., Ridgefield, New Jersey, USA)) was used as a
source of nutrition (feed) during biofilm formation.
Traditional Biofilm (TBF) MBEC model
Traditional biofilm was formed in the MBEC system
(Innovotech Ltd, Calgary, Alberta) under sterile condi-
tions in a Class II B3 biosafety cabinet. Biofilm formation
(and related controls) were established on and recovered
from the pegs based on the manufacturer's recommenda-
tions and methods of Ceri et al. [13] and Harrison et al.
[14]. The ATS was used for inoculation of pegs and for
feeding. Pegs were exposed to ATS and organisms for 24
hours at RT to establish biofilm formation on all pegs.
After 24 hours, the MBEC pegs were rinsed and all pegs
were fed on a daily basis with ATS or tap water for 30 days.
Pegs were removed and assayed at various intervals to
monitor biofilm progression.
Biofilm recovery from MBEC pegs
For biofilm recovery, a 96-well microtitre plate was pre-
pared by adding 200 uL of sPBS per well. Alternately,
when small numbers of pegs were recovered, rinsing took
place in 500 uL sPBS per sterile microcentrifuge tube for
each removed peg. Individual pegs were broken off the lid
by placing a sterile haemostat at the lid/peg interface and
breaking the peg off. Pegs were briefly rinsed in sPBS, 3
times for 20 seconds, to remove nonadherent material.
The rinsed pegs were transferred to recovery tubes con-
taining sPBS in either a volume of 500 uL in a microfuge
tube or in 1 mL in a 2 mL snap-cap test tube (Simport,
Quebec, Canada). Tubes were shaken on a shaker table at
high speed for 2 min, sonicated at 50/60 Hertz using a
Bransonic 1200 Ultrasonic cleaner (Branson Canada,
Pickering ON) for 5 minutes and vortexed for 1 minute.
This recovery method has been recommended for MBEC
pegs [13,14].
Viability assay
Quantitative assessment (viable counts) of recovered via-
ble biofilm bacteria was achieved using serial 1:10 dilu-
tions in sPBS in conjunction with the spread plate
technique on TSA or BA. The limit of detection for the via-
bility assay was 10 CFU/peg.
Buildup biofilm (BBF) model development
The BBF model
To model the buildup of material in a way that mimicked
patient-used flexible endoscopes over time the MBEC pegs
were exposed to repetitive cycles of treatments that were
representative of the endoscope reprocessing protocol.
This modelling approach was designed to evaluate micro-
bial survivability in BBF formed by treatments that were
repetitive cycles of drying, disinfectant exposure and re-
exposure to the test organism.
Treatment cycles of 2 days mimicked overnight reprocess-
ing conditions. Inoculated pegs were fed with nutrient
media or HLD treatment post drying on alternating days.
All test sampling was done immediately pre- and post-
treatment cycle on triplicate sample pegs.
The MBEC pegs were inoculated using ATS for all experi-
ments. The media used to feed the biofilm growth wasBMC Infectious Diseases 2009, 9:56 http://www.biomedcentral.com/1471-2334/9/56
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ATS (representing a high organic matrix), sterile tap water
(representing a low organic matrix, as found in scope rins-
ing), or an enzymatic detergent (representing a moderate
organic matrix, as found in scope cleaning). For all treat-
ments, drying was done ON (12 to 18 hours) at RT in a
biosafety cabinet. HLD was achieved using glutaraldehyde
and accelerated hydrogen peroxide (for 20 minute expo-
sure times at RT as per manufacturer's recommendations).
Following disinfectant exposure, pegs were neutralized
using 10% FBS in TSB (for 10 minutes) to eliminate the
possibility of disinfectant carryover to the recovery
medium.
The Cyclic BBF model
To more closely resemble environments in the reprocess-
ing scheme, biofilm growth was evaluated in enzymatic
detergent (as used in the cleaning process) compared to
sTAP (similar to endoscope rinsing stages). As well repet-
itive re-exposure to bioburden (as would be encountered
for each new endoscopic procedure) finalized the cycle.
The sample pegs were removed before and after HLD and
evaluated for microbial survival.
BBF controls
Recoverable TBF bioburden was used as a positive control
to define the CFU per peg for continuously formed bio-
film. The TBF control was formed in MBEC plates at the
same time, with the same inoculum samples, supplied
with the same nutrient media lot, and with sample pegs
removed and challenged with the same disinfectant lot
and working solution at the same specified test times and
conditions as for BBF. All test results were from a mini-
mum of 9 replicates resulting from a minimum of tripli-
cate replications from 3 separate trials.
To monitor the possibility of contamination or cross-con-
tamination due to the cycling procedure, negative pegs
(exposed to medium only) were located throughout the
plate in sufficient numbers (resulting in a minimum of 3
negative pegs per test cycle).
Outgrowth testing
Following HLD, sample pegs were aseptically transferred
into 10% FBS in TBS in sterile tubes that remained
unopened at 35°C for 5 days. These tubes were subjected
to the standard elution protocol (shaking for 2 minutes,
sonication for 5 minutes, vortexing for 1 minute) however
the tubes remained closed. The tubes with pegs were re-
incubated for 25 days at 35°C. Turbidity indicated posi-
tive growth and if no turbidity was seen, the broth was still
subbed to TSA or BA.
Concurrent to removing test pegs for the indirect qualita-
tive outgrowth test, replicate sample pegs were removed
and directly examined for viability by the quantitative via-
bility counting method and direct qualitative outgrowth
test for comparison. All testing was done on triplicate pegs
in three separate trials (9 replicates in total). Controls
were as stated previously.
Statistical Analysis
For biofilm formation on MBEC pegs, the following statis-
tical analyses were performed as suggested by Harrison et
al. [14] including, determination of mean, standard devi-
ation and one-way analysis of variance (ANOVA) compar-
ing the mean viable cell counts of pooled rows within and
between plates. These analyses were used to verify that the
described method for biofilm inoculation and formation
of each test organism produced equivalent biofilm growth
on different rows within and between the MBEC plates
over the test period of 30 days. For comparison of TBF and
BBF and the resultant bioburden following HLD chal-
lenge, the Student's t-test (unpaired, two-tailed) was used,
as in similar studies [18].
Results
The survival of a range of representative microorganisms
(bacteria, and fungi) in TBF and BBF was evaluated to
determine the impact of an organic matrix and disinfect-
ant chemistry. The modelling system produced reproduc-
ible results and MBEC statistical analyses showed no
significant variation in counts regardless of peg location
on or between plates, indicating equivalent biofilm for-
mation. Resulting statistical determinations using
ANOVA for each test organism were: E. faecalis, p = 0.252;
P. aeruginosa, p = 0.153; and C. albicans, p = 0.893. Valida-
tion of the recovery method used to harvest biofilm and
BBF from the pegs was performed using a standard live/
dead fluorescent staining technique. Microscopic exami-
nation of the pegs before and after repeated rounds of har-
vesting from the pegs indicated that essentially 100% of
organisms on the peg were recovered by the first round of
harvesting (data not shown).
We specifically chose to evaluate GLUT efficacy using 20
minutes exposure at room temperature rather than using
the manufacturer's recommended exposure time of 45
minutes at 25°C. This was done because in clinical set-
tings it is widely accepted that 20 minutes is appropriate
for HLD using GLUT. The use of GLUT exposure for 20
minutes exposure at room temperature for HLD is stated
in the current APIC guideline as acceptable providing the
endoscope has been thoroughly cleaned [12].
TBF was formed by allowing pegs to remain hydrated
between test periods. The ability of E. faecalis, P. aerugi-
nosa, and C. albicans to form TBF under high or low nutri-
ent conditions and the survivability of these organisms
when challenged with HLD using GLUT at various time
points over the test period is shown in Figure 1. A signifi-BMC Infectious Diseases 2009, 9:56 http://www.biomedcentral.com/1471-2334/9/56
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Traditional biofilm (TBF): impact of Glutaraldehyde on microbial survival Figure 1
Traditional biofilm (TBF): impact of Glutaraldehyde on microbial survival. P. aeruginosa (a), E. faecalis (b), and C. 
albicans (c), were used to form TBF in high nutrient medium (ATS) or low nutrient medium (tap water). Sample pegs carrying 
TBF on their surface were removed after varying time periods and the bioburden determined after no treatment (positive con-
trol) or after drying followed by treatment with 2.6% Glutaraldehyde for 20 minutes. TBF untreated (blue bar), TBF treated 
with Glutaraldehyde (red bar).
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cantly higher number of surviving organisms (p < 0.0001)
resulted for all test organisms when TBF was formed
under high compared to low nutrient medium.
BBF was formed under conditions of repetitive cycles of
drying, HLD and bioburden exposure, mimicking a com-
plete endoscope reprocessing scheme. Two-day cycles
were repeated over 30 days with survivability within the
BBF examined after each cycle. All data represent BBF
seeded in ATS with biofilm developed in either enzymatic
detergent or water with cyclic exposure to treatment con-
ditions as stated above. Figure 2 describes survivability of
the test organisms in BBF formed under high and low
nutrient conditions and challenged with HLD using GLUT
at various test times. For all test organisms, a significantly
higher number of organisms survived GLUT challenge
when BBF was formed under high compared to low nutri-
ent medium (p < 0.0001).
Figures 3 and 4 are similar to Figures 1 and 2 respectively,
however HLD is achieved with AHP. All test organisms
also showed significantly higher numbers of resulting
organisms (p < 0.0001) when either TBF or BBF were
formed under high compared to low nutrient conditions.
Additional statistical analyses of maximum resultant
microbial loads following HLD challenge demonstrated
significant differences (p < 0.0001) for all organisms in
the following comparisons: TBF compared to BBF chal-
lenged with either GLUT or AHP; GLUT compared to AHP
challenge of either BBF or TBF; BBF formed under high
nutrient conditions compared to TBF formed under low
nutrient conditions, when challenged with GLUT; BBF
formed after 10 cycles compared to TBF after a single
cycle, with formation under high nutrient conditions and
exposure to GLUT.
Table 1 summarizes the breakthrough survival to various
disinfectant challenges of test organisms grown under
tested conditions for biofilm formation. The time period
to detectable survival was similar in TBF (recorded in
days) and BBF (recorded in 2-day cycles) for all organisms
except  P. aeruginosa, which required longer times for
detectable survival in cyclic BBF than for TBF.
Table 2 summarizes the rate of survival in TBF and BBF
grown under high nutrient conditions (i.e., ATS for TBF
and enzymatic detergent for BBF). Overall BBF demon-
strated significantly greater increase in survivability once
survivors were detectable particularly following GLUT
challenge (p < 0.0001).
The qualitative indirect outgrowth testing method was
used to establish the detectibility and recoverability of
damaged and/or low levels of viable organisms embedded
within TBF or BBF. This protocol encouraged the release of
embedded organisms by sonication coupled with recov-
ery and growth in enriched media over 30 days. Results,
shown in Table 3, detail BBF resulting from repeated
cycles of drying and HLD (without re-exposure to biobur-
den) to assess whether low levels of microbial survival in
BBF occurs. Results indicate that despite no detectable via-
ble organisms for the quantitative counts (limit of detec-
tion 10 cfu/peg), there can be low- level microbial survival
to GLUT in TBF and BBF.
When similarly challenged with AHP HLD, survival was
detected in mature TBF for E. faecalis and P. aeruginosa by
indirect qualitative outgrowth and quantitative counts.
Similar to the GLUT challenge, as TBF matured, surviva-
bility to AHP increased. However, detection of viability
following AHP challenge required longer recovery times,
occurred on fewer pegs, resulted in lower numbers of sur-
vivors compared to GLUT challenge, and AHP survival
was detected less frequently in BBF compared to TBF
(Table 3).
Overall, the results indicated that the indirect qualitative
outgrowth was a more sensitive method to detect the pres-
ence of viable organisms than the quantitative viability
counting method.
Discussion
Biofilm formation has been suggested in reprocessed flex-
ible endoscopes in spite of adequate reprocessing,
[3,2,11,12,19,20] however the practical effect of such bio-
film on reprocessing efficacy and infection transmission is
unknown [21]. Our experimental results show that both
traditional biofilm formation (TBF) and buildup biofilm
formation (BBF) reduced the efficacy of microbial killing
by the two HLDs evaluated in this study, which is similar
to what has been reported [22] for the effect that TBF has
on the killing efficacy of antibiotics. Formation under
high nutrient conditions resulted in a higher microbial
load in a growing biofilm compared to one formed under
low nutrient conditions. Avid biofilm formation, particu-
larly under high nutrient conditions (e.g. with P. aerugi-
nosa and C. albicans) related to earlier survival to HLD.
These findings support clinical data suggesting these
organisms are difficult pathogens to eliminate in by the
endoscopic disinfection process, [4,21] the importance of
reducing organic levels during reprocessing, as well as
their strong association with medical implant and dental
water unit infections [20,23]. Even when biofilm was
formed under low nutrient conditions, if challenged with
a cross-linking disinfectant, survival resulted. This further
emphasizes that dry storage is imperative to maintain a
contaminant free scope after storage and before reuse.BMC Infectious Diseases 2009, 9:56 http://www.biomedcentral.com/1471-2334/9/56
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Buildup biofilm (BBF): impact of Glutaraldehyde on microbial survival Figure 2
Buildup biofilm (BBF): impact of Glutaraldehyde on microbial survival. P. aeruginosa (a), E. faecalis (b), and C. albicans 
(c), were used to form BBF in high nutrient medium (enzymatic detergent) or low nutrient medium (tap water). Sample pegs 
carrying BBF on their surface were removed after varying time periods and the bioburden determined after no treatment (pos-
itive control) or after treatment with 2.6% Glutaraldehyde for 20 minutes, where every peg with BBF received multiple cycles 
of treatment as described in Methods. BBF untreated (blue bar), BBF treated with multiple rounds of drying, Glutaraldehyde, 
and bioburden exposure (red bar).
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Traditional biofilm (TBF): impact of Accelerated Hydrogen Peroxide on microbial survival Figure 3
Traditional biofilm (TBF): impact of Accelerated Hydrogen Peroxide on microbial survival. P. aeruginosa (a), E. 
faecalis (b), and C. albicans (c), were used to form TBF in high nutrient medium (ATS) or low nutrient medium (tap water). Sam-
ple pegs carrying TBF on their surface were removed after varying time periods and the bioburden determined after no treat-
ment (positive control) or after drying followed by treatment with 7% Accelerated hydrogen peroxide (AHP) for 20 minutes. 
TBF untreated (blue bar), TBF treated with AHP (red bar).
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Buildup biofilm (BBF): impact of Accelerated Hydrogen peroxide on microbial survival Figure 4
Buildup biofilm (BBF): impact of Accelerated Hydrogen peroxide on microbial survival. P. aeruginosa (a), E. faecalis 
(b), and C. albicans (c), were used to form BBF in high nutrient medium (enzymatic detergent) or low nutrient medium (tap 
water). Sample pegs carrying BBF on their surface were removed after varying time periods and the bioburden determined 
after no treatment (positive control) or after treatment with 7% Accelerated hydrogen peroxide (AHP) for 20 minutes, where 
every peg with BBF received multiple cycles of treatment as described in Methods. BBF untreated (blue bar), BBF treated with 
multiple rounds of drying, AHP, and bioburden exposure (red bar).
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Based on the live/dead fluorescent validation tests that we
performed and since we performed the peg harvesting in
accordance with published methods using the MBEC peg
model [13,14] we have assumed that recovery is 100%.
The results of the TBF and BBF models in this study indi-
cate that HLD is effective at killing bioburden within
young biofilm but not mature biofilm and highlight the
value in studying biofilm formation in reprocessed scopes
over extended periods of time. Our data suggests that deep
within the biofilm structure (either TBF or BBF), organ-
isms are protected (likely by ECM and organic material)
from the disinfectant challenge, particularly from GLUT
challenge. This supports current concerns regarding the
exposure of low concentrations or activities of biocides to
organisms embedded within biofilm and the selection of
tolerant bacteria, [2,24] particularly in BBF. The BBF
model demonstrated for the first time that although a
longer time was needed for organisms to be detected
within the BBF compared to TBF, outgrowth of surviving
bioburden in BBF was faster and the ultimate level
achieved was greater for BBF. These data provide a possi-
ble explanation for published reports describing the per-
sistence of residual levels of organisms in scope channels
even when proper reprocessing is followed [11,21].
Table 1: Summary of Initiation of breakthrough survival in various biofilm formations
Breakthrough initiation1
Nutrient
medium
Organism TBF
Treatment:
GLUT
BBF
Treatment: GLUT
TBF
Treatment:
AHP
BBF
Treatment:
AHP
High2 E. faecalis 15 7 24 12
P. aeruginosa 659 8
C. albicans 95 1 5 7
Low3 E. faecalis 30 15 NBD4 NBD
P. aeruginosa 18 12 NBD NBD
C. albicans 24 13 NBD NBD
The day (in TBF) or cycle (in BBF) when breakthrough growth was first detected in traditional biofilm or buildup biofilm formed by repetitive 
exposure to drying, HLD, and reseeding. Results are an average of 9 replicates; SD ≤ 10%.
1 For TBF, the breakthrough time is recorded in days. For BBF, the breakthrough time is recorded in cycles (of a 2-day cycling period).
2 High nutrient media (ATS (for TBF) or Enzymatic detergent (for BBF))
3 Low nutrient media (Water)
4 NBD: no breakthrough detected; limit of detection for viability counting is 10 cfu/peg
Table 2: Rate of biofilm survival in TBF1 and BBF1 following HLD with GLUT and AHP
Rate of survival2
Organism TBF
Treatment:
GLUT
BBF
Treatment: GLUT
TBF
Treatment:
AHP
BBF
Treatment:
AHP
E. faecalis 2 10 2.3 3.1
P. aeruginosa 2 8.6 3.4 4.9
C. albicans 2 9.3 3.4 3.8
1 TBF and BBF grown under high nutrient conditions
2 Rate of survival was calculated by the ratio of:
Maximum Log10CFU/Initial breakthrough Log10CFUBMC Infectious Diseases 2009, 9:56 http://www.biomedcentral.com/1471-2334/9/56
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The data from this study supports the value of using the
BBF for research and development of improved endo-
scope reprocessing methods. For example, although Mar-
ion et al. [19] and Vickery et al. [2] have reported that
detergents capable of stripping biofilm from the channels
of flexible endoscopes are more effective, this conclusion
was reached using TBF (formed from a single round of
conditions reflecting endoscope usage on carriers or in
actual scopes) which may be easier to remove than BBF.
Therefore, implications for endoscope reprocessing based
on studies of young TBF challenged with a disinfectant
may not be indicative of the kill ability of organisms in
endoscopes repeatedly used and reprocessed over the life
of a scope. Studies of BBF may offer an additional level of
stringency and relevance to endoscope reprocessing com-
pared to studies of TBF with a single round testing also in
determining the efficacy of anti-biofilm agents (e.g. tran-
sition metal catalysts, acylated homoserine lactone mole-
cules or biofilm detaching agents) [19].
An enzymatic detergent's role is to remove patient soil by
the "digestive" action of the various enzymes included in
Table 3: Survival of organisms embedded in TBF or BBF1 following HLD2: indirect qualitative outgrowth testing compared to 
quantitative viability3 results
Microorganism:
BFF
Average cfu/peg4 (Log10) Outgrowth5
# Positive/#Tested
Average time to detection (days) for outgrowth
HLD: 2.6% GLUT:
P. aeruginosa:
TBF – Day 3 <LD6 3/9 4
TBF – Day 15 3.7 7/9 1
TBF – Day 30 4.8 9/9 1
BBF – Day 3 <LD 4/9 20
BBF – Day 15 <LD 2/9 10
BBF – Day 30 1.9 2/9 1
HLD: 7% AHP:
P. aeruginosa:
TBF – Day 3 <LD 0/9 -
TBF – Day 15 1.6 4/9 1
TBF – Day 30 2.5 4/9 1
BBF – Day 3 <LD 0/9 -
BBF – Day 15 <LD 0/9 -
BBF – Day 30 <LD 0/9 -
1 3-day cyclical drying/HLD in ATS medium
2 HLD for cyclic BBF pegs and sample pegs of TBF (formed in ATS)
3 Quantitative viability testing on replicate pegs (without enhanced recovery protocol)
4 Average of 9 pins
5 Indirect qualitative outgrowth (enhanced recovery protocol):
TBF or BBF peg placed in 10%FBS-TSB, shake/sonicate/vortex (as per extraction
method), then continue to incubate at 35°C/30d
6LD: limit of detection is 10 cfu/peg for quantitative viability countsBMC Infectious Diseases 2009, 9:56 http://www.biomedcentral.com/1471-2334/9/56
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the formulation. These formulations do not claim to kill
microorganisms. The results of our data demonstrate the
ability of organisms to replicate in enzymatic detergent at
the manufacturer's recommended use-dilution when held
at room temperature overnight (normal contact time rec-
ommended by the manufacturer for cleaning is at least 5
minutes). Therefore the practice (although not recom-
mended) of leaving patient-used scopes in enzymatic
detergent overnight or over the weekend can serve to
increase rather than reduce microbial load and protein
buildup, thereby hindering efficacy of the disinfection
process. This also supports the need to thoroughly rinse
endoscopes after the cleaning phase. Furthermore, it raises
the question of whether enzymatic detergents are really
the optimal approach or whether other types of detergents
(e.g. alkaline or surfactant-associated) could be developed
that would be superior and that might have microbial kill-
ing ability.
The results of our in vitro model study showed that high-
level disinfection using glutaraldehyde was less effective
than AHP for killing microorganisms in either TBF or BBF.
The benefits of AHP chemistry in bioburden reduction
have been cited in published reports [25]. In-use studies
of GI endoscope disinfection have shown HLD alterna-
tives to aldehyde chemistry (such as oxidants, e.g. perace-
tic acid and 13% H2O2 -27% lactic acid; aromatic
dialdehydes, e.g. ortho-ophthalaldehyde; and quaternary
ammonium iodides, e.g. N-duopropenida) have a supe-
rior ability to reduce bacterial loads [26]. As indicated by
other researchers similar chemistries warrant further stud-
ies [19,26,27]. Our data is the first to demonstrate an oxi-
dant's efficacy in TBF and BBF conditions. For example,
breakthrough survival was consistently detected sooner
with GLUT than with AHP and the ability of microbes to
survive exposure to GLUT occurred irrespective of the
organic levels used during biofilm formation. Whereas,
AHP consistently eliminated detectable viability in all TBF
and BBF formed under low nutrient conditions. Although
GLUT has an extremely long global track record as a HLD
for reprocessing heat-sensitive medical devices, our study
demonstrates for the first time that GLUT is not a very
effective method to ensure microorganisms are eradi-
cated. Indeed, after only 10 cycles of BBF formation P. aer-
uginosa consistently survived HLD using GLUT at levels of
~6 Log10/peg. The implication of these findings is that
organisms remain trapped or embedded due to repetitive
GLUT cycles that cross-link organic material forming a
protective layer shielding them from the HLD. Once
microbial survival within the BBF is established then
"grow out" occurs quickly once reintroduced into a moist
environment. This scenario supports findings by other
researchers describing the kill ability of glutaraldehyde in
biofilm but inability to remove bioburden with subse-
quent impairment of cleaning [18]. However in contrast,
the study of TBF and particularly BBF in this research
allowed for the detection of viable organisms within this
fixed bioburden.
Data from this study highlights the possibility that non-
detectibility of viable organisms may not imply efficacy of
HLD, particularly in BBF formed by repeated exposure to
a cross-linking agent. The determination of the absence of
residual microorganisms following reprocessing is
dependent on the sensitivity of the detection method
[26]. In this in-vitro study using the MBEC peg system for
BBF qualitative outgrowth in an enriched medium pre-
sented a more sensitive method of bacterial detection, as
has been shown in in-use testing of actual endoscopes fol-
lowing cleaning and disinfection [26]. However this study
further utilized an indirect qualitative outgrowth method
for enhanced microbial recovery of trapped or damaged
microorganisms. Another promising method for the
measurement of low levels of infectious agents and pro-
tein has also been suggested by Lipscomb et al. [28] using
differential interference contrast microscopy and the fluo-
rescent agent, SYPRO Ruby.
Data from our study suggest that current guidelines for
testing of new liquid chemical disinfectants/sterilants that
are based on a single cycle of testing, may not reflect the
true efficacy over multiple rounds of reprocessing of a
reusable device. The implications are that as flexible endo-
scopes are repeatedly used and reprocessed, the load of
bioburden increases, as does the risk of transmission of
pathogens. This study is the first to provide experimental
data that may provide an explanation for reported obser-
vations indicating that problems with microbial contami-
nation of endoscopes occur after repeated use – not when
the scopes are first put into use [22,3]. Our evaluation uti-
lized GLUT exposure conditions of 20 minutes of room
temperature to ensure the in vitro model being developed
reflected what is currently accepted in clinical practice
[27,15]. It is possible that exposure using the FDA cleared
manufacturer's label claim of 45 minutes at room temper-
ature would show different results for GLUT. Despite this
caveat, the data presented in this manuscript support the
value of performing similar prospective assessments in
patient-used flexible endoscopes to determine the clinical
relevance of our findings. Again it should be noted that
there are no published clinical reports that directly link
increased risk of infection transmission for flexible endo-
scopes that are reprocessed by glutaraldehyde compared
to other HLDs.
Conclusion
Many models of biofilm exist, but they do not account for
the repeated use that is inherent for reusable medical
devices. The BBF model described in this study provides a
novel approach that closely mimics the conditions andBMC Infectious Diseases 2009, 9:56 http://www.biomedcentral.com/1471-2334/9/56
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cyclic nature of biofilm formation in patient-used flexible
endoscopes. The model included repetitive exposure to
organic sources (ATS or enzymatic detergent), bioburden,
HLD, rinsing and drying. The BBF model, utilizing
repeated cycles of exposure to high levels of organic mate-
rial containing high loads of microorganisms, more
closely replicates endoscope reprocessing; whereas tradi-
tional biofilm formation in hydrated, low nutritive condi-
tions does not accurately model what happens in flexible
endoscopes that are stored dry. The data presented in this
BBF modelling study using the MBEC peg system sug-
gested that early in the life of a reprocessed endoscope,
microbial survival may not be detectable (due to low
numbers, damage or entrapment of organisms) however
over time as scopes are continuously used and reproc-
essed, rapidly escalating numbers of surviving microor-
ganisms can result when a cross-linking agent such as
GLUT is used as the HLD with exposure times of 20 min-
utes at room temperature.
The novel BBF model developed in this report uses condi-
tions that are more likely to reflect the in-use conditions
experienced by flexible endoscopes (i.e. cyclic rounds of
exposure that mimics reprocessing stages) than those con-
ditions used for traditional biofilm models (i.e. constant
hydration). Our MBEC model of BBF may offer valuable
insight that can be used to provide evidence based data
that would be instructive in advancing current reprocess-
ing guidelines. Overall, the impact of the data from this
research shows for the first time that the survival of a wide
range of microorganisms can occur in BBF and that the
kinetics and rapid outgrowth is significantly faster com-
pared to TBF, which is much less common in medical
devices that are stored under dry conditions. Therefore,
the data from our in vitro model suggest that for patient-
used endoscopes the chance of organisms surviving device
reprocessing and being transmitted to another patient
would be greater if BBF has developed within the endo-
scope channels. Further clinical studies are warranted to
further evaluate our findings as there are no publications
documenting any increased risk of infection transmission
for endoscopes processed using GLUT as the HLD.
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